( NASDAQ-NMS:SGMO,NASDAQ-NMS:SHPGY,RICS:SHP.L,RICS:SHPGY.O,LSE:SHP )

News from sangamo biosciences, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 10, 2016, 16:03 ET Sangamo BioSciences Announces Participation At Upcoming Investor Conferences

 Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Edward Lanphier, Sangamo's president...


May 09, 2016, 07:00 ET Sangamo BioSciences Presents Recent Developments From Research And ZFP Therapeutic® Programs In Multiple Presentations At Annual Meeting of the American Society of Gene and Cell Therapy

 Sangamo BioSciences, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, presented new preclinical data from the Company's...


May 02, 2016, 16:05 ET Sangamo BioSciences Reports First Quarter 2016 Financial Results

Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, today reported its first quarter 2016 financial results and...


Apr 28, 2016, 16:03 ET Sangamo BioSciences Announces Presentation At The Deutsche Bank 41st Annual Health Care Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Edward Lanphier, Sangamo's president...


Apr 25, 2016, 16:03 ET Sangamo BioSciences Announces First Quarter 2016 Conference Call and Webcast

 Sangamo BioSciences, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, today announced that the company will release its first...


Apr 18, 2016, 16:03 ET Sangamo BioSciences Announces Presentations On ZFP Therapeutic® Programs And Applications At 2016 Annual Meeting Of The American Society Of Gene & Cell Therapy

 Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced that data from several ZFP Therapeutic programs...


Mar 15, 2016, 16:03 ET Sangamo BioSciences Announces Participation In The 4th Annual Cell & Gene Therapy Investor Day Meeting In New York

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Elizabeth Wolffe, Ph.D., Sangamo's vice president, corporate communications,...


Mar 02, 2016, 07:00 ET Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform Programs For MPS I And MPS II At The 12th Annual WORLDSymposium™ Meeting

 Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced the presentation of new preclinical data in...


Mar 01, 2016, 16:03 ET Sangamo BioSciences Announces Presentation At The Cowen And Company 36th Annual Health Care Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Edward Lanphier, Sangamo's president...


Feb 24, 2016, 16:03 ET Sangamo BioSciences Presents Phase 2 Immunological Data from SB-728-T ZFP Therapeutic® HIV Program at CROI 2016

 Sangamo BioSciences, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, announced the presentation of immunological data from the...


Feb 09, 2016, 16:03 ET Sangamo BioSciences Reports Fourth Quarter And Full Year 2015 Financial Results

 Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, today reported its fourth quarter and full year...


Feb 08, 2016, 07:00 ET Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I

 Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced that the U.S. Food and Drug Administration (FDA)...


Feb 04, 2016, 16:03 ET Sangamo BioSciences Announces Presentation At The Leerink Partners 5th Annual Global Healthcare Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Edward Lanphier, Sangamo's president...


Feb 02, 2016, 16:03 ET Sangamo BioSciences Announces Fourth Quarter And Full Year 2015 Conference Call And Webcast

Sangamo BioSciences, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, today announced that the company will release its fourth...


Jan 11, 2016, 07:00 ET Sangamo BioSciences Highlights 2016 Catalysts at the 34th Annual J.P. Morgan Healthcare Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced that Edward Lanphier, Sangamo's president and...


Jan 05, 2016, 16:03 ET Sangamo BioSciences Announces Presentation At The 34th Annual J.P. Morgan Healthcare Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Edward Lanphier, Sangamo's president...


Dec 11, 2015, 07:00 ET Sangamo BioSciences Presents Phase 2 Clinical Data From Two SB-728-T HIV Studies

 Sangamo BioSciences, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, announced the presentation of Phase 2 data from two of the...


Dec 07, 2015, 07:00 ET Sangamo BioSciences Presents Data At The 2015 American Society Of Hematology Meeting Highlighting ZFP Therapeutic® Programs For Hemophilia And Hemoglobinopathies

 Sangamo BioSciences, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, announced the presentation of data from its ZFP...


Dec 01, 2015, 07:00 ET Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, First In Vivo Protein Replacement Platform Program For Treatment Of Hemophilia B

Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced that the U.S. Food and Drug Administration (FDA) has...


Nov 23, 2015, 16:05 ET Sangamo BioSciences Announces Presentation At The 2015 Piper Jaffray Healthcare Conference

Sangamo BioSciences, Inc. (NASDAQ: SGMO), a leader in therapeutic genome editing, announced today that Edward Lanphier, Sangamo's president and...


Nov 11, 2015, 16:05 ET Sangamo BioSciences Announces Presentation At The Jefferies Autumn 2015 Global Healthcare Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO), a leader in therapeutic genome editing, announced today that Geoffrey Nichol, M.B., Ch.B., Sangamo's...


Nov 09, 2015, 11:49 ET Sangamo BioSciences Announces Publication Of Improved Method For Efficient Targeted Integration In Hematopoietic Stem Cells And T-cells

 Sangamo BioSciences, Inc. (Nasdaq: SGMO), a leader in therapeutic genome editing, announced today the publication in Nature Biotechnology of...


Nov 05, 2015, 16:05 ET Sangamo BioSciences To Present Data From ZFP Therapeutic Programs At Annual Meeting Of The American Society Of Hematology

Sangamo BioSciences, Inc. (Nasdaq: SGMO), a leader in therapeutic genome editing, announced today that non-human primate data from its proprietary...


Oct 28, 2015, 16:05 ET Sangamo BioSciences Reports Third Quarter 2015 Financial Results

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its third quarter 2015 financial results and accomplishments. For the third quarter...


Oct 21, 2015, 16:02 ET Sangamo BioSciences Announces Third Quarter 2015 Conference Call and Webcast

Sangamo BioSciences, Inc. (NASDAQ: SGMO) today announced that the company will release its third quarter 2015 financial results after the market...